Novo Nordisk Vs. Eli Lilly Q3 Preview: I'd (Now) Buy Both, But Lilly Is My Top Pick (NVO)

Novo Nordisk (NVO) Stock Declines While Market Improves: Some Information for Investors

Sector Update: Healthcare Stocks Decline Late Afternoon

Novo Nordisk Vs. Eli Lilly Q3 Preview: I'd (Now) Buy Both, But Lilly Is My Top Pick

Novo Nordisk (CPSE:NOVO B) Wins FDA Nod For Weekly Insulin In Children With Type 2 Diabetes

Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?

US Judge Denies Novo Nordisk Request To Block Eli Lilly Weight Loss Drug Ads

Buy, Sell or Hold LLY Stock? Key Factors to Watch Ahead of Q3 Earnings

Orbis Medicines Appoints Joanne Smith-Farrell, Ph.D., as CEO to Advance Its AI-Driven Oral Macrocycle Platform and Pipeline

Omnicom: Stock Rallied On Strong Growth, Still A Bargain At An 8x P/E

Novo Nordisk Loses Court Bid Against Eli Lilly’s Weight-Loss Drug Ads — Judge Says Sales Impact Was Negligible

Dear Eli Lilly Stock Fans, Mark October 29 on Your Calendar

Novo Nordisk A/S Reports Share Repurchase Transactions Under DKK 15 billion Programme

Novo Nordisk A/S - share repurchase programme

3 Massive Catalysts That Could Ignite an Eli Lilly Stock Rally on Oct 29